À titre de membre permanent, vous pourrez accéder au contenu éditorial et de formation continue, utiliser le moteur de recherche, recevoir nos newsletters, participer aux discussions, télécharger des diapositives et plus encore.
Investigators think that elevated natriuretic peptide levels in brain-dead heart donors could potentially be more powerful than troponins as a predictor of posttransplant outcomes.
Continued experience with ventricular-assist device supports the generally good outcomes seen in the previously reported pivotal ADVANCE trial, but an unexpectedly high rate of device-related thrombus cooled the investment community on the device's prospects, at least for now.
Mechanical circulatory support as a bridge to retransplant could be a reasonable strategy one year in, but not for primary graft failure or hyperacute rejection.
An experimental cardiac repair cell product using autologous expanded bone-marrow cells substantially improved signs and symptoms of severe heart failure in patients, according to study results.
One possible reason for the declining use of high-risk heart donors is the increasing use of left ventricular assist devices, which are becoming more effective therapeutic modalities.
A strategy in which everolimus was added to a reduced-dose cyclosporine regimen improved renal function in approximately 50% of patients, Italian investigators report.
Types of complications following implantation of an LVAD include transient ischemic attack or ischemic or hemorrhagic stroke, a retrospective review from a single center suggests.
Among the main reasons for first readmission were infection, bleeding, planned procedure, device malfunction, and neurological complications. Experts, however, say the rate of readmissions is "acceptable" given the dismal readmission rates seen with traditional heart-failure therapy in these very ill patients.
